Greg A. Lazar
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Molecular Biology top 5%
- Immunology top 2%
- Oncology top 5%
- Materials Chemistry
- Co-authors
- John R. DesjarlaisPaul J. CarterSher KarkiHsing ChenTracy M. HandelWei DangGregory L. MooreIrene Leung
- Topics
- Monoclonal and Polyclonal Antibodies Research (34 papers)Glycosylation and Glycoproteins Research (10 papers)Protein purification and stability (10 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Greg A. Lazar
44 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Radiology, Nuclear Medicine and Imaging 2.2k
- Molecular Biology 2.1k
- Immunology 1.2k
- Oncology 755
- Materials Chemistry 239
Countries citing papers authored by Greg A. Lazar
This map shows the geographic impact of Greg A. Lazar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg A. Lazar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg A. Lazar more than expected).
Fields of papers citing papers by Greg A. Lazar
This network shows the impact of papers produced by Greg A. Lazar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg A. Lazar. The network helps show where Greg A. Lazar may publish in the future.
Co-authorship network of co-authors of Greg A. Lazar
This figure shows the co-authorship network connecting the top 25 collaborators of Greg A. Lazar. A scholar is included among the top collaborators of Greg A. Lazar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg A. Lazar. Greg A. Lazar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 11 | |
| 3 | 6 | |
| 4 | 4 | |
| 5 | Next generation antibody drugs: pursuit of the 'high-hanging fruit'breakdown → | 564 |
| 6 | 22 | |
| 7 | 89 | |
| 8 | 449 | |
| 9 | 193 | |
| 10 | 235 | |
| 11 | 119 | |
| 12 | 96 | |
| 13 | Engineered antibody Fc variants with enhanced effector functionbreakdown → | 590 |
| 14 | 78 | |
| 15 | 41 | |
| 16 | 60 | |
| 17 | 4 | |
| 18 | 134 | |
| 19 | 34 | |
| 20 | 37 |
About Greg A. Lazar
Greg A. Lazar is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology, having authored 44 papers that have together received 3.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (10 papers) and Protein purification and stability (10 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.2k citations), Immunology (1.2k citations) and Molecular Biology (2.1k citations). Greg A. Lazar has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include John R. Desjarlais, Paul J. Carter, Sher Karki, Hsing Chen, Tracy M. Handel, Wei Dang, Gregory L. Moore, Irene Leung, Holly M. Horton and Jonathan Zalevsky. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.